Brentford / München / Umea / Aberdeen / Bergen / Southampton / Barcelona / Krakow / Budapest / Södertälje / Bern / Leusden / Paris / Stockholm / BIOAIR / Rome / Copenhagen / Milan / Parma / Ingelheim / London / Brussels / Basel / Solna / Marseille / Horsham / /
Company
Novartis Pharma AG / Synairgen Research Limited / UK Pfizer Limited / Germany Chiesi Farmaceutici S.p.A / Switzerland UCB Pharma SA / BioSci Consulting / Development LTD / Spain AstraZeneca AB / Switzerland Laboratorios Almirall S.A. / GlaxoSmithKline / Aerocrine AB / F. Hoffmann-La Roche AG / International GmbH / Novartis Development Novartis Pharma AG / Philips Electronics Nederland B.V. / /
Country
Netherlands / Sweden / Belgium / United Kingdom / Denmark / /
Currency
EUR / /
Event
Diplomatic Relations / /
Facility
Sweden University of Nottingham / Hungary University of Manchester / UK Imperial College of Science / Italy Hvidovre Hospital / Denmark The Jagiellonian University Medical College / University of Copenhagen / F5-259 Academic Medical Centre / Italy University of Rome / The University of Southampton / Germany Umeå University / /
MedicalCondition
Switzerland Asthma UK / patients' asthma / asthma / disease / BTS Severe Asthma / MRC Southampton Severe Asthma / distinct severe asthma / severe asthma / /
OperatingSystem
Aix / /
Organization
University of Rome / National Institute of Health / Germany Umeå University / Jagiellonian University Medical College / University of Manchester / Manchester / Lausanne / Italy Hvidovre Hospital / College of Science / the Netherlands European Lung Foundation / European Federation of Pharmaceutical Industries and Associations / Sweden University of Nottingham / Nottingham / European Union / Poland Universität Bern / University of Copenhagen / UK European Federation of Asthma and Allergy Associations / University of Southampton / F5-259 Academic Medical Centre / /
Person
Tor Vergata / Sacro Cuore / Christopher Compton Respiratory Franchise / Christopher Compton / Peter Sterk / / /
IMI 1ST CALL PROJECTS: EFFICACY U-BIOPRED UNBIASED BIOMARKERS FOR THE PREDICTION OF RESPIRATORY DISEASE OUTCOMES SUMMARY: